EVP Issa Mohamed Khairie sold 10,856 shares of INCY at $109.07 for $1,184,063.92; retains 66,132 shares post-transaction.
Issa Mohamed Khairie, EVP Head of US Oncology at Incyte, sold 10,856 shares at $109.07 on 2026-01-07, representing a 14.1% reduction in his holdings from 76,988 to 66,132 shares. The sale occurred at a price just 1.4% below the 52-week high of $110.57, during a period when the stock has posted strong momentum (up 11.3% over 30 days and 26.4% over 90 days). Incyte's fundamentals remain solid with 14.8% annual revenue growth and a P/E of 17.51. The transaction is material in absolute terms ($1.2M) but represents a modest fractional reduction of his stake, leaving him with substantial remaining exposure to the company.